115 related articles for article (PubMed ID: 263356)
1. Nomifensine: diagnostic test in hyperprolactinemic states.
Müller EE; Genazzani AR; Murru S
J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
[TBL] [Abstract][Full Text] [Related]
3. Nomifensine in the diagnosis of hyperprolactinemia.
Gullo D; Carmina E; Mogavero G; Perino A; Venezia R
Acta Eur Fertil; 1981 Dec; 12(4):299-306. PubMed ID: 7342611
[TBL] [Abstract][Full Text] [Related]
4. Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.
Ferrari C; Crosignani PG; Caldara R; Picciotti MC; Malinverni A; Barattini B; Rampini P; Telloli P
J Clin Endocrinol Metab; 1980 Jan; 50(1):23-6. PubMed ID: 7188615
[TBL] [Abstract][Full Text] [Related]
5. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
[TBL] [Abstract][Full Text] [Related]
6. Approach to the diagnosis of hyperprolactinemic states: the nomifensine and domperidone tests.
Molinatti GM; Camanni F; Cocchi D; De Leo V; Genazzni AR; Massara F; Muller EE
Panminerva Med; 1981; 23(1):5-10. PubMed ID: 7290727
[No Abstract] [Full Text] [Related]
7. Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women.
Minuto F; Barbarino A; Baviera G; Mazzocchi G; De Marinis L; Leonardi R; Bernasconi D; Menini E; Maira G; Anile C
J Endocrinol Invest; 1984 Apr; 7(2):137-40. PubMed ID: 6725869
[TBL] [Abstract][Full Text] [Related]
8. Prolactin lowering effect of amphetamine in normoprolactinemic subjects and in physiological and pathological hyperprolactinemia.
DeLeo V; Cella SG; Camanni F; Genazzani AR; Müller EE
Horm Metab Res; 1983 Sep; 15(9):439-43. PubMed ID: 6642414
[TBL] [Abstract][Full Text] [Related]
9. Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
Pontiroli AE; Loda G; Roggia A; Scagliola P; Falsetti L
Acta Endocrinol (Copenh); 1982 Oct; 101(2):171-9. PubMed ID: 7136447
[TBL] [Abstract][Full Text] [Related]
10. Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists.
Genazzani AR; De Leo V; Murru S; Cocchi D; Camanni F; Müller EE
J Clin Endocrinol Metab; 1982 Feb; 54(2):429-35. PubMed ID: 7054227
[No Abstract] [Full Text] [Related]
11. [Progress in the hormonal detection of pituitary prolactin adenoma].
De Gennes JL; Turpin G; Heshmati HM; Carayon A
Ann Med Interne (Paris); 1982; 133(1):12-6. PubMed ID: 7065584
[No Abstract] [Full Text] [Related]
12. Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology.
Camanni F; Genazzani AR; Massara F; de Leo V; Molinatti GM; Müller EE
J Clin Endocrinol Metab; 1980 Sep; 51(3):650-3. PubMed ID: 7410539
[No Abstract] [Full Text] [Related]
13. Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas.
Iannotta F; Fachinetti P; Fachinetti A; Pinotti G; Usellini L
J Endocrinol Invest; 1983 Oct; 6(5):353-8. PubMed ID: 6420458
[TBL] [Abstract][Full Text] [Related]
14. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
Abraham G
Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
[No Abstract] [Full Text] [Related]
15. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
Moriondo P; Travaglini P; Nissim M; Faglia G
Clin Endocrinol (Oxf); 1980 Dec; 13(6):525-33. PubMed ID: 7226570
[TBL] [Abstract][Full Text] [Related]
16. Nomifensine test does not differentiate hyperprolactinemia associated with and without radiologic abnormalities in the sella turcica.
Canales ES; Cano C; Ablanedo J; Zárate A
Horm Res; 1981; 15(4):213-7. PubMed ID: 6927819
[TBL] [Abstract][Full Text] [Related]
17. Agreement of prolactin response to cimetidine and nomifensine in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
Iodice M; Lombardi G; Tommaselli A; Rossi R; Annunziato L; Minozzi M
Neuroendocrinology; 1982 Nov; 35(5):333-5. PubMed ID: 7145025
[No Abstract] [Full Text] [Related]
18. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
Barbarino A; De Marinis L; Maira G; Menini E; Anile C
J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
[TBL] [Abstract][Full Text] [Related]
19. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
[TBL] [Abstract][Full Text] [Related]
20. Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia.
Dallabonzana D; Spelta B; Botalla L; Oppizzi G; Silvestrini F; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1982 Jun; 54(6):1125-8. PubMed ID: 7076795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]